中文 | English
Return
Total: 84 , 1/9
Show Home Prev Next End page: GO
MeSH:(Hypertension, Pulmonary/drug therapy)

1.Current practice for pulmonary hypertension.

Toru SATOH

Chinese Medical Journal 2014;127(19):3491-3495

6.Association of asymmetric dimethylarginine with the pathological process of persistent pulmonary hypertension of the newborn.

Wen-Ting ZHANG ; Qin LU ; Jie-Jun DING ; Meng GU

Chinese Journal of Contemporary Pediatrics 2022;24(1):54-59

7.Efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn: a Metaanalysis.

Ling-Xue LI ; Bing WEI ; Ming YANG ; Mo LI ; Jing-Jing JIA

Chinese Journal of Contemporary Pediatrics 2022;24(3):319-325

8.Natural ingredients from Chinese materia medica for pulmonary hypertension.

Jia-Rui ZHANG ; Xuan OUYANG ; Chi HOU ; Qi-Feng YANG ; Yingjun WU ; Wen-Ju LU ; Chun-Li LIU ; Kai YANG ; Nan-Shan ZHONG ; Jian WANG ; Yu-Qin CHEN

Chinese Journal of Natural Medicines (English Ed.) 2021;19(11):801-814

9.A clinical analysis of 15 children with systemic lupus erythematosus accompanied by pulmonary hypertension.

Ji LI ; Jing-Ran MA ; Zhi-Xing SUN ; Jing-Jing JIANG ; Yan-Qing DONG ; Qian WANG ; Hong-Mei SONG

Chinese Journal of Contemporary Pediatrics 2017;19(6):658-662

10.Acute effect of tetrandrine pulmonary targeting microspheres on hypoxic pulmonary hypertension in rats.

Deyun CHENG ; Wenbin CHEN ; Xiaoneng MO

Chinese Medical Journal 2002;115(1):81-83

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 84 , 1/9 Show Home Prev Next End page: GO